Vitality Medical reports that Hawai‘i faces the largest gap between sleep therapy needs and access, with 45.4% of residents ...
An industrial X-ray CT scan shows the internal design of the ResMed AirSense 10 AutoSet CPAP device used by millions of sleep ...
I initiate coverage of ResMed with a Hold rating, citing dominant OSA positioning but near-term competitive headwinds. RMD’s recurring revenue model leverages device sales, consumables, and SaaS, with ...
ResMed went public in 1995 and has grown to a recent market value of nearly $38 billion. Its stock has averaged annual gains of 15.6% over the past 15 years, and 16.9% over the past 10. The stock's ...
Is the cannula comfortable and flexible? Yes, patient comfort is a key feature of this product. The SleepSense Adult Nasal Pressure Monitoring Cannula is constructed from a soft and flexible material ...
ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business model. I rate RMD a strong sell due to the imminent threat from Apnimed's ...
In 2025, the U.S. Food and Drug Administration (“FDA”) and U.S. Department of Justice (“DOJ”) pursued significant criminal, civil, and regulatory enforcement actions grounded in longstanding ...
Do all of your Black Friday shopping from the comfort of your couch (or under the Thanksgiving table while ignoring your family). By Stan Horaczek, Tony Ware Updated Nov 28, 2025 3:53 PM EST Add ...
The Therapeutic Goods Administration has launched legal proceedings against Philips Electronics in the Federal Court over the sale of breathing devices between 2019 and 2022. The TGA alleges the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results